Advagene Biopharma Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced operating loss was TWD 125.659 million compared to TWD 149.485 million a year ago. Net loss was TWD 111.323 million compared to TWD 138.127 million a year ago. Basic loss per share was TWD 3.16 compared to TWD 4.77 a year ago.